Clinical

Dataset Information

0

Phase II Clinical Trial of Antigen pulsed dendritic cells (APDC)


ABSTRACT: Interventions: Group A (control):Modified FOLFOX chemotherapy (5 days 3 weeks) 3 cycles;Group B (treatment):Modified FOLFOX chemotherapy (5 days 3 weeks) for 3 cycles; APDC biological immunotherapy for 2 cycles; 4 times in total Primary outcome(s): Objective efficienc Study Design: Randomized parallel controlled trial

DISEASE(S): Metastatic Colorectal Cancer

PROVIDER: 2672674 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2024-03-06 | GSE260661 | GEO
| 2194539 | ecrin-mdr-crc
| S-EPMC3903525 | biostudies-literature
2016-12-14 | PXD001889 | Pride
2024-05-21 | PXD044201 | Pride
2023-09-01 | E-MTAB-12949 | biostudies-arrayexpress
2023-09-01 | E-MTAB-12950 | biostudies-arrayexpress
2023-09-01 | E-MTAB-12952 | biostudies-arrayexpress
2023-09-01 | E-MTAB-12953 | biostudies-arrayexpress
| 2621365 | ecrin-mdr-crc